<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37583958</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairment after long COVID-19: current evidence and perspectives.</ArticleTitle><Pagination><StartPage>1239182</StartPage><MedlinePgn>1239182</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1239182</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2023.1239182</ELocationID><Abstract><AbstractText>COVID-19, caused by the SARS-CoV-2 virus, is a respiratory infectious disease. While most patients recover after treatment, there is growing evidence that COVID-19 may result in cognitive impairment. Recent studies reveal that some individuals experience cognitive deficits, such as diminished memory and attention, as well as sleep disturbances, suggesting that COVID-19 could have long-term effects on cognitive function. Research indicates that COVID-19 may contribute to cognitive decline by damaging crucial brain regions, including the hippocampus and anterior cingulate cortex. Additionally, studies have identified active neuroinflammation, mitochondrial dysfunction, and microglial activation in COVID-19 patients, implying that these factors may be potential mechanisms leading to cognitive impairment. Given these findings, the possibility of cognitive impairment following COVID-19 treatment warrants careful consideration. Large-scale follow-up studies are needed to investigate the impact of COVID-19 on cognitive function and offer evidence to support clinical treatment and rehabilitation practices. In-depth neuropathological and biological studies can elucidate precise mechanisms and provide a theoretical basis for prevention, treatment, and intervention research. Considering the risks of the long-term effects of COVID-19 and the possibility of reinfection, it is imperative to integrate basic and clinical research data to optimize the preservation of patients' cognitive function and quality of life. This integration will also offer valuable insights for responding to similar public health events in the future. This perspective article synthesizes clinical and basic evidence of cognitive impairment following COVID-19, discussing potential mechanisms and outlining future research directions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Li, Zhang, Zhang, Wang and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Zhitao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Zhuoya</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">post-COVID cognitive impairment</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>3</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37583958</ArticleId><ArticleId IdType="pmc">PMC10423939</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1239182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Synowiec A, Szczepa&#x144;ski A, Barreto-Duran E, Lie LK, Pyrc K. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection. Clin Microbiol Rev. (2021) 34:2. 10.1128/CMR.00133-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00133-20</ArticleId><ArticleId IdType="pmc">PMC7849242</ArticleId><ArticleId IdType="pubmed">33441314</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Resp Med. (2020) 8:475&#x2013;81. 10.1016/S2213-2600(20)30079-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. . Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. (2020) 20:669&#x2013;77. 10.1016/S1473-3099(20)30243-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez J, Perez-Rojo G, Noriega C, Carretero I, Velasco C, Martinez-Huertas JA, et al. . Psychological well-being among older adults during the COVID-19 outbreak: a comparative study of the young-old and the old-old adults. Int Psychogeriatrics. (2020) 32:1365&#x2013;70. 10.1017/S1041610220000964</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610220000964</ArticleId><ArticleId IdType="pmc">PMC7324658</ArticleId><ArticleId IdType="pubmed">32438934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Yu M. Severe acute respiratory syndrome coronavirus 2-induced neurological complications. Front Cell Develop Biol. (2020) 8:605972. 10.3389/fcell.2020.605972</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.605972</ArticleId><ArticleId IdType="pmc">PMC7758195</ArticleId><ArticleId IdType="pubmed">33363165</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Tawfiq JA, Azhar EI, Memish ZA, Zumla A. Middle East respiratory syndrome coronavirus. Semin Respir Crit Care Med. (2021) 42:828&#x2013;38. 10.1055/s-0041-1733804</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1733804</ArticleId><ArticleId IdType="pubmed">34918324</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. (2008) 82:7264&#x2013;75. 10.1128/JVI.00737-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clinical and applied thrombosis/hemostasis. J Int Acad Clin Appl Thrombosis/Hemostasis. (2020) 26:1076029620938149. 10.1177/1076029620938149</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620938149</ArticleId><ArticleId IdType="pmc">PMC7370334</ArticleId><ArticleId IdType="pubmed">32677459</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 International journal of infectious diseases. IJID. (2020) 94:55&#x2013;8. 10.1016/j.ijid.2020.03.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. (2020) 19:383&#x2013;4. 10.1016/S1474-4422(20)30109-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Balanz&#xe1;-Mart&#xed;nez V, Luperdi SC, Estrada I, Latorre A, Gonz&#xe1;lez-Jim&#xe9;nez P, et al. . Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med. (2021) 290:621&#x2013;31. 10.1111/joim.13262</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13262</ArticleId><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. (2021) 94:138&#x2013;47. 10.1016/j.bbi.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, Malsy J, P&#xf6;ttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, et al. . Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. (2020) 2:fcaa205. 10.1093/braincomms/fcaa205</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Mannan O, Eyre M, L&#xf6;bel U, Bamford A, Eltze C, Hameed B, et al. . Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. (2020) 77:1440&#x2013;5. 10.1001/jamaneurol.2020.2687</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2687</ArticleId><ArticleId IdType="pmc">PMC7330822</ArticleId><ArticleId IdType="pubmed">32609336</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. . Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. (2021) 218:135. 10.1084/jem.20202135</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yongzhi X. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue. Emerg Microbes Infect. (2021) 10:266&#x2013;76. 10.1080/22221751.2021.1884503</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1884503</ArticleId><ArticleId IdType="pmc">PMC7894425</ArticleId><ArticleId IdType="pubmed">33522893</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis AG, Elhadd K, Camera V, Ferreira Dos Santos M, Rocchi C, Adib-Samii P, et al. . Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination. Neurol Neuroimmunol Neuroinflamm. (2023) 10:63. 10.1212/NXI.0000000000200063</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200063</ArticleId><ArticleId IdType="pmc">PMC9679888</ArticleId><ArticleId IdType="pubmed">36411077</ArticleId></ArticleIdList></Reference><Reference><Citation>Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E, et al. . Sympathetic activation: a potential link between comorbidities and COVID-19. The FEBS J. (2020) 287:3681&#x2013;8. 10.1111/febs.15481</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15481</ArticleId><ArticleId IdType="pmc">PMC7405290</ArticleId><ArticleId IdType="pubmed">32779891</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir Res. (2020) 21:198. 10.1186/s12931-020-01462-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01462-5</ArticleId><ArticleId IdType="pmc">PMC7385717</ArticleId><ArticleId IdType="pubmed">32723327</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, Pinto CB, Detwiler S, Mukli P, Peterfi A, Szarvas Z, et al. . Cerebral small vessel disease pathology in COVID-19 patients: a systematic review. Ageing Res Rev. (2023) 88:101962. 10.1016/j.arr.2023.101962</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2023.101962</ArticleId><ArticleId IdType="pmc">PMC10202464</ArticleId><ArticleId IdType="pubmed">37224885</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Wang YR, Wang QH, Chen Y, Chen X, Li Y, et al. . Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. (2021) 16:48. 10.1186/s13024-021-00469-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00469-w</ArticleId><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Lana S, Marqui&#xe9; M, Ruiz A, Boada M. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front Aging Neurosci. (2020) 12:588872. 10.3389/fnagi.2020.588872</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.588872</ArticleId><ArticleId IdType="pmc">PMC7649130</ArticleId><ArticleId IdType="pubmed">33192483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. . Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalMedicine. (2022) 53:101651. 10.1016/j.eclinm.2022.101651</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W, et al. . Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimer J Alzheimer's Assoc. (2022) 18:1047&#x2013;66. 10.1002/alz.12644</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. (2022) 269:44&#x2013;6. 10.1007/s00415-021-10655-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadad R, Khoury J, Stanger C, Fisher T, Schneer S, Ben-Hayun R, et al. . Cognitive dysfunction following COVID-19 infection. J Neurovirol. (2022) 28:430&#x2013;7. 10.1007/s13365-022-01079-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-022-01079-y</ArticleId><ArticleId IdType="pmc">PMC9134977</ArticleId><ArticleId IdType="pubmed">35618983</ArticleId></ArticleIdList></Reference><Reference><Citation>Baseler HA, Aksoy M, Salawu A, Green A, Asghar AUR. The negative impact of COVID-19 on working memory revealed using a rapid online quiz. PLoS ONE. (2022) 17:e0269353. 10.1371/journal.pone.0269353</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0269353</ArticleId><ArticleId IdType="pmc">PMC9662713</ArticleId><ArticleId IdType="pubmed">36374838</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19-a review on objective test data. Front Neurol. (2021) 12:699582. 10.3389/fneur.2021.699582</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M, Cano N, Segura B, Adan A, Bargall&#xf3; N, Cald&#xfa; X, et al. . Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints. Front Aging Neurosci. (2022) 14:1029842. 10.3389/fnagi.2022.1029842</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1029842</ArticleId><ArticleId IdType="pmc">PMC9631485</ArticleId><ArticleId IdType="pubmed">36337708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, et al. . Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. (2020) 25:100484. 10.1016/j.eclinm.2020.100484</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein TL. Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 &#x201c;long haulers&#x201d;. BMC Neurol. (2023) 23:22. 10.1186/s12883-023-03049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-023-03049-1</ArticleId><ArticleId IdType="pmc">PMC9843113</ArticleId><ArticleId IdType="pubmed">36647063</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Bech JL, Henriksen AC, Johnsen S, Podlekareva D, Marner L. Cerebral metabolic rate of glucose and cognitive tests in long COVID patients. Brain Sci. (2022) 13:23. 10.3390/brainsci13010023</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13010023</ArticleId><ArticleId IdType="pmc">PMC9856023</ArticleId><ArticleId IdType="pubmed">36672005</ArticleId></ArticleIdList></Reference><Reference><Citation>Muccioli L, Sighinolfi G, Mitolo M, Ferri L, Jane Rochat M, Pensato U, et al. . Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction. NeuroImage Clinical. (2023) 38:103410. 10.1016/j.nicl.2023.103410</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2023.103410</ArticleId><ArticleId IdType="pmc">PMC10165139</ArticleId><ArticleId IdType="pubmed">37104928</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson DV, Miskowiak KW, Pedersen JK, Hansen H, Podlekareva D, Johnsen S, Dall CH. Physical function and association with cognitive function in patients in a post-COVID-19 clinic-a cross-sectional study. Int J Environ Res Public Health. (2023) 20:5866. 10.3390/ijerph20105866</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20105866</ArticleId><ArticleId IdType="pmc">PMC10218564</ArticleId><ArticleId IdType="pubmed">37239592</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, et al. . One-Year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. (2022) 79:509&#x2013;17. 10.1001/jamaneurol.2022.0461</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Annals Clin Translat Neurol. (2021) 8:1073&#x2013;85. 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168&#x2013;75. 10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Hossinger A, Heum&#xfc;ller SE, Hornberger A, Buravlova O, Konstantoulea K, et al. . Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. Nat Commun. (2021) 12:5739. 10.1038/s41467-021-25855-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25855-2</ArticleId><ArticleId IdType="pmc">PMC8526834</ArticleId><ArticleId IdType="pubmed">34667166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, et al. . SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. (2023) 42:112189. 10.1016/j.celrep.2023.112189</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer's Res Therapy. (2020) 12:69. 10.1186/s13195-020-00640-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. (2022) 612:758&#x2013;63. 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, et al. . Should we stimulate or suppress immune responses in COVID-19? Cytokine Anti-cytokine Intervent Autoimmun Rev. (2020) 19:102567. 10.1016/j.autrev.2020.102567</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102567</ArticleId><ArticleId IdType="pmc">PMC7196557</ArticleId><ArticleId IdType="pubmed">32376392</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. (2020) 92:814&#x2013;8. 10.1002/jmv.25801</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25801</ArticleId><ArticleId IdType="pmc">PMC7262125</ArticleId><ArticleId IdType="pubmed">32253759</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung AL, Vanderheiden A, Nordvig AS, Sissoko CA, Canoll P, Mariani MB, et al. . COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain J Neurol. (2022) 145:4193&#x2013;201. 10.1093/brain/awac270</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank T, Prinz M. Microglia as modulators of cognition and neuropsychiatric disorders. Glia. (2013) 61:62&#x2013;70. 10.1002/glia.22372</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22372</ArticleId><ArticleId IdType="pubmed">22740320</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks WA, Ortiz L, Plotkin SR, Kastin AJ. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther. (1991) 259:988&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">1762091</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. . Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. (2021) 39:101044. 10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf3;brega F, Mauad VAQ, Borducchi DMM. Does COVID-19 really impact on the oxy-hemoglobin dissociation curve? EJHaem. (2020) 1:604&#x2013;7. 10.1002/jha2.126</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jha2.126</ArticleId><ArticleId IdType="pmc">PMC9175707</ArticleId><ArticleId IdType="pubmed">35845000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mussa BM, Srivastava A, Verberne AJM. COVID-19 and neurological impairment: hypothalamic circuits and beyond. Viruses. (2021) 13:498. 10.3390/v13030498</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030498</ArticleId><ArticleId IdType="pmc">PMC8002703</ArticleId><ArticleId IdType="pubmed">33802995</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MA, Scholey AB. Nutritional influences on human neurocognitive functioning. Front Hum Neurosci. (2014) 8:358. 10.3389/fnhum.2014.00358</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2014.00358</ArticleId><ArticleId IdType="pmc">PMC4034604</ArticleId><ArticleId IdType="pubmed">24904390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H, et al. . Microvascular injury in the brains of patients with COVID-19. N Engl J Med. (2021) 384:481&#x2013;3. 10.1056/NEJMc2033369</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin J, Frosch MP, Mukerji SS, Rapalino O, Maher MD, Schaefer PW, et al. . Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J Neurol Sci. (2021) 421:117308. 10.1016/j.jns.2021.117308</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117308</ArticleId><ArticleId IdType="pmc">PMC7832284</ArticleId><ArticleId IdType="pubmed">33497950</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Kempuraj D. Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID. Cells. (2023) 12:688. 10.3390/cells12050688</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="pubmed">36899824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball EE, Weiss CM, Liu H, Jackson K, Keel MK, Miller CJ, et al. . Severe acute respiratory syndrome coronavirus 2 vasculopathy in a syrian golden hamster model. Am J Pathol. (2023) 193:690&#x2013;701. 10.1016/j.ajpath.2023.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2023.02.013</ArticleId><ArticleId IdType="pmc">PMC9998130</ArticleId><ArticleId IdType="pubmed">36906263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadwa EH, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Albogami SM, Alorabi M, et al. . Cholinergic dysfunction in COVID-19: frantic search and hoping for the best. Naunyn-Schmiedeberg's Arch Pharmacol. (2023) 396:453&#x2013;68. 10.1007/s00210-022-02346-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-022-02346-9</ArticleId><ArticleId IdType="pmc">PMC9735034</ArticleId><ArticleId IdType="pubmed">36460816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong R, Lam E, Bramante CT, Johnson SG, Reusch J, Wilkins KJ, et al. . Does COVID-19 infection increase the risk of diabetes? Current evidence. Curr Diab Reports. (2023) 3:1&#x2013;10. 10.1007/s11892-023-01515-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-023-01515-1</ArticleId><ArticleId IdType="pmc">PMC10244847</ArticleId><ArticleId IdType="pubmed">37284921</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza SM, Ebrahim F, Ekea H, Ali SK. COVID-19 Presenting as a Seizure: a Kenyan case report. Cureus. (2022) 14:e24431. 10.7759/cureus.24431</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24431</ArticleId><ArticleId IdType="pmc">PMC9128310</ArticleId><ArticleId IdType="pubmed">35637806</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeilly AD, Gallagher JR, Evans ML, de Galan BE, Pedersen-Bjergaard U, Thorens B, et al. . Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes. Diabetologia. (2023) 66:1340&#x2013;52. 10.1007/s00125-023-05907-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-023-05907-6</ArticleId><ArticleId IdType="pmc">PMC10244284</ArticleId><ArticleId IdType="pubmed">37015997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Sun Y, Qian Z, Wang Z, Zhang D, Li Z, et al. . Long-term dietary folic acid supplementation attenuated aging-induced hippocampus atrophy and promoted glucose uptake in 25-month-old rats with cognitive decline. J Nutr Biochem. (2023) 117:109328. 10.1016/j.jnutbio.2023.109328</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2023.109328</ArticleId><ArticleId IdType="pubmed">36958416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertas B, Hazar-Yavuz AN, Topal F, Keles-Kaya R, Karakus &#xd6;, Ozcan GS, et al. . Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats. J Ethnopharmacol. (2023) 313:116541. 10.1016/j.jep.2023.116541</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2023.116541</ArticleId><ArticleId IdType="pubmed">37088237</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. (2021) 8:416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J, Lepra M, Kish SJ, Rusjan PM, Nasser Z, Verhoeff N, et al. . Neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms. JAMA Psychiatry. (2023). 10.1001/jamapsychiatry.2023.1321</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. (2022) 604:697&#x2013;707. 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. (2022) 110:3484&#x2013;96. 10.1016/j.neuron.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020) 87:18&#x2013;22. 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, et al. . Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. (2023) 12:5. 10.3390/cells12050816</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuley R, Duvvuri B, Wallin JJ, Bui N, Adona MV, O'Connor NG, et al. . Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19. Virulence. (2023) 14:2218077. 10.1080/21505594.2023.2218077</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2023.2218077</ArticleId><ArticleId IdType="pmc">PMC10231045</ArticleId><ArticleId IdType="pubmed">37248708</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannelli R, Canale P, Del Carratore R, Falleni A, Bernardeschi M, Forini F, et al. . Ultrastructural and molecular investigation on peripheral leukocytes in Alzheimer's disease patients. Int J Mol Sci. (2023) 24:909. 10.3390/ijms24097909</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24097909</ArticleId><ArticleId IdType="pmc">PMC10178539</ArticleId><ArticleId IdType="pubmed">37175616</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J., Jr., Leung BP, Rezai-Zadeh K, Town T. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron. (2015) 85:534&#x2013;48. 10.1016/j.neuron.2014.12.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.068</ArticleId><ArticleId IdType="pmc">PMC4352138</ArticleId><ArticleId IdType="pubmed">25619654</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold D, Farztdinov V, Yan Y, Meisel C, Sadlowski H, K&#xfc;hn J, et al. . The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation. J Neuroinflammation. (2023) 20:30. 10.1186/s12974-023-02711-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02711-2</ArticleId><ArticleId IdType="pmc">PMC9909638</ArticleId><ArticleId IdType="pubmed">36759861</ArticleId></ArticleIdList></Reference><Reference><Citation>Toklu H, Ganti L, Crimi E, Cintron C, Hagan J, Serrano E. Cerebrospinal fluid findings and hypernatremia in COVID-19 patients with altered mental status. Int J Emerg Med. (2020) 13:63. 10.1186/s12245-020-00327-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12245-020-00327-4</ArticleId><ArticleId IdType="pmc">PMC7724453</ArticleId><ArticleId IdType="pubmed">33297938</ArticleId></ArticleIdList></Reference><Reference><Citation>Akanchise T, Angelova A. Ginkgo Biloba and long COVID: in vivo and in vitro models for the evaluation of nanotherapeutic efficacy. Pharmaceutics. (2023) 15:1562. 10.3390/pharmaceutics15051562</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15051562</ArticleId><ArticleId IdType="pmc">PMC10224264</ArticleId><ArticleId IdType="pubmed">37242804</ArticleId></ArticleIdList></Reference><Reference><Citation>He D, Yuan M, Dang W, Bai L, Yang R, Wang J, et al. . Long term neuropsychiatric consequences in COVID-19 survivors: cognitive impairment and inflammatory underpinnings 15 months after discharge. Asian J Psychiatr. (2023) 80:103409. 10.1016/j.ajp.2022.103409</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103409</ArticleId><ArticleId IdType="pmc">PMC9751007</ArticleId><ArticleId IdType="pubmed">36549172</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedjasukmana R, Budikayanti A, Islamiyah WR, Witjaksono A, Hakim M. Sleep disturbance in post COVID-19 conditions: prevalence and quality of life. Front Neurol. (2022) 13:1095606. 10.3389/fneur.2022.1095606</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1095606</ArticleId><ArticleId IdType="pmc">PMC9869804</ArticleId><ArticleId IdType="pubmed">36698905</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. 10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalamara E, Pataka A, Boutou A, Panagiotidou E, Georgopoulou A, Ballas E, et al. . Persistent sleep quality deterioration among post-COVID-19 patients: results from a 6-month follow-up study. J Pers Med. (2022) 12:11. 10.3390/jpm12111909</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12111909</ArticleId><ArticleId IdType="pmc">PMC9692708</ArticleId><ArticleId IdType="pubmed">36422085</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellitteri G, Surcinelli A, De Martino M, Fabris M, Janes F, Bax F, et al. . Sleep alterations following COVID-19 are associated with both neuroinflammation and psychological disorders, although at different times. Front Neurol. (2022) 13:929480. 10.3389/fneur.2022.929480</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.929480</ArticleId><ArticleId IdType="pmc">PMC9428349</ArticleId><ArticleId IdType="pubmed">36062000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Pandi-Perumal SR. SARS-CoV-2 infection: paving way for sleep disorders in long term! Sleep Vigilance. (2021) 5:1&#x2013;2. 10.1007/s41782-021-00145-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41782-021-00145-5</ArticleId><ArticleId IdType="pmc">PMC8126505</ArticleId><ArticleId IdType="pubmed">34027301</ArticleId></ArticleIdList></Reference><Reference><Citation>Numbers K, Brodaty H. The effects of the COVID-19 pandemic on people with dementia. Nat Rev Neurol. (2021) 17:69&#x2013;70. 10.1038/s41582-020-00450-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00450-z</ArticleId><ArticleId IdType="pmc">PMC7786184</ArticleId><ArticleId IdType="pubmed">33408384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn M, LaMori J, DeMartino JK, Mesa-Frias M, Doran J, Korrapati L, et al. . Assessing barriers to access and equity for COVID-19 vaccination in the US. BMC Public Health. (2022) 22:2263. 10.1186/s12889-022-14636-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14636-1</ArticleId><ArticleId IdType="pmc">PMC9719622</ArticleId><ArticleId IdType="pubmed">36463172</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>